The Role of Aspirin After High-Risk Percutaneous Coronary Intervention: The Ticagrelor with Aspirin or Alone in High-Risk Patients After Coronary Intervention Clinical Trial Experience
Publication date: October 2020Source: Interventional Cardiology Clinics, Volume 9, Issue 4Author(s): Zain Ul Abideen Asad, Usman Baber
Source: Interventional Cardiology Clinics - Category: Cardiology Source Type: research
More News: Angioplasty | Aspirin | Cardiology | Clinical Trials | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention